Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine

European Journal of Pediatrics

Volumn 161, Issue 3, 2002, Pages 142-146

  Lugauer, Siegfried ^a   Heininger, Ulrich ^a,c   Cherry, James D ^b   Stehr, Klemens ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Acellular pertussis vaccine; Efficacy; Long term; Pertussis; Whole cell pertussis vaccine

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIPHTHERIA; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; PERTUSSIS; PHYSICIAN; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TETANUS;

CLINICAL TRIALS; COHORT STUDIES; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FOLLOW-UP STUDIES; HUMANS; INFANT; QUESTIONNAIRES; SWEDEN; WHOOPING COUGH;

EID: 0036182478     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-001-0893-5     Document Type: Article

References (40)

1. Epidemiology of pertussis in French hospitals in 1993 and 1994: Thirty years after a routine use of vaccination
2. Bordetella pertussis and chronic cough in adults
3. Infant immunization with acellular pertussis vaccines in the United States: Assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS)
4. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: A comparative study
5. Comparison of antibody values to Bordetella pertussis antigens in young German and American men
6. Epidemiological, clinical, and laboratory aspects of pertussis in adults
7. The science and fiction of pertussis vaccines
8. Household contact study of Bordetella pertussis infections
9. Is pertussis a frequent cause of cough in adolescents and adults? Should routine pertussis immunization be recommended?
10. The recurrence of whooping cough: Possible implications for assessment of vaccine efficacy
11. Reflections on the efficacy of pertussis vaccines
12. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis
13. A controlled trial of a two-component acellular, a five-component acellular and a whole-cell pertussis vaccine
14. Recent progress in clinical and basic pertussis research
15. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents
16. Evaluation of pertussis in U.S. Marine Corps Trainees
17. Duration of effectiveness of pertussis vaccine: Evidence from a 10-year community study
18. Epidemiology of a small pertussis outbreak in Kent County, Michigan
19. Efficacy of a two-component acellular pertussis vaccine in infants
20. Reemergence of pertussis in the highly vaccinated population of the Neth-erlands: Observations on surveillance data
21. A search for Bordetella pertussis infection in university students
22. Outbreak of pertussis in a fully immunized adolescent and adult population
23. The changing epidemiology of pertussis in young infants: The role of adults as reservoirs of infection
24. Prevalence and incidence of adult pertussis in an urban population
25. Epidemiology of pertussis in Denmark: The impact of herd immunity
26. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the study of pertussis vaccines
27. Bordetella pertussis infection: A cause of persistent cough in adults
28. Pertussis infection among adults during the 1993 outbreak in Chicago
29. Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines
30. Efficacy of two 3-component DTaP vaccines over five years of follow-up from the Italian trial
31. Efficacy of acellular pertussis vaccine in early childhood after household exposure
32. Pertussis in German adults
33. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal
34. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine or DT vaccine
35. Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants
36. A placebo-controlled trial of a pertussis-toxoid vaccine
37. Pertussis vaccine
38. The effectiveness of pertussis vaccine: An application of Sargent and Merrell's method of measurement
39. Pertussis in adults: Frequency of transmission after household exposure
40. Pertussis infections in adults with persistent cough